Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease

Alzheimer's disease (AD) is the most common form of dementia and aging is the most common risk factor for developing the disease. The etiology of AD is not known but AD may be considered as a clinical syndrome with multiple causal pathways contributing to it. The amyloid cascade hypothesis, cla...

Full description

Saved in:

Bibliographic Details
Published in:	Neuropsychiatric disease and treatment Vol. 17; pp. 1311 - 1339
Main Authors:	Fulop, Tamas, Tripathi, Shreyansh, Rodrigues, Serafim, Desroches, Mathieu, Bunt, Ton, Eiser, Arnold, Bernier, Francois, Beauregard, Pascale B, Barron, Annelise E, Khalil, Abdelouahed, Plotka, Adam, Hirokawa, Katsuiku, Larbi, Anis, Bocti, Christian, Laurent, Benoit, Frost, Eric H, Witkowski, Jacek M
Format:	Journal Article
Language:	English
Published:	New Zealand Dove Medical Press Limited 01.01.2021 Taylor & Francis Ltd Dove Medical Press Dove
Subjects:	Age Aging Alzheimer's disease Antimicrobial activity Antimicrobial agents antimicrobial immunity Biomarkers Brain Brain research Causes of Central nervous system diseases Chronic infection Cognitive science Complications and side effects Cytokines Cytomegalovirus Dementia disorders Development and progression Dynamical Systems Etiology Health aspects Immune clearance Immune response Immune system Immunity (Disease) Infections Inflammation Mathematics Memory Metabolism Microorganisms mild cognitive impairment Neurodegeneration Neurodegenerative diseases neuroinflammation Neuroscience Oxidative stress Pathology Peptides Physiological aspects Prevention Review Risk factors Senile plaques treatment Canada treatment mild cognitive impairment Alzheimer’s disease antimicrobial immunity brain neuroinflammation
ISSN:	1178-2021, 1176-6328, 1178-2021
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!